NCT01937182View on ClinicalTrials.gov

The Efficacy of Citalopram Treatment in Acute Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

642

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 19, 2016

Study Completion Date

December 19, 2016

Conditions
Stroke, Ischemic
Interventions
DRUG

Citalopram

Citalopram 10-40 mg per day administered orally

DRUG

Placebo

1/2-2 tablets per day with no intrinsic drug activity

Trial Locations (3)

2600

Glostrup University Hospital, Department of Neurology, Glostrup Municipality

8000

Aarhus University Hospital, Department of Neurology, Aarhus

9100

Aalborg University Hospital, Department of Neurology, Aalborg

All Listed Sponsors
collaborator

Danish Council for Independent Research

OTHER

collaborator

The Danish Regions Medicine Foundation

UNKNOWN

lead

University of Aarhus

OTHER

NCT01937182 - The Efficacy of Citalopram Treatment in Acute Stroke | Biotech Hunter | Biotech Hunter